Roland Rutschmann
Vermogen: 28 M $ op 30-09-2026
Vermogen: 28 M $ op 30-09-2026
Roland Rutschmann currently works at Curatis Holding AG, as Chief Executive Officer & Executive Director from 2024.
Mr. Rutschmann also formerly worked at Actelion Ltd., as Vice President-Strategic Marketing & GM and Orphan Europe SARL, as General Manager from 2009 to 2011.
Mr. Rutschmann received his doctorate degree from the University of Basel.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
23,43% | 31-12-2025 | 1.245.000 ( 23,43% ) | 28 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Corporate Officer/Principal | 01-01-2011 |
| ACTELION | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau